Consensus building and recommendations based on the available epidemiology of meningococcal disease in Gulf

Related Experiment Video

Updated: Jun 4, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Ziad A Memish1, Atef M Shibl

  • 1Ministry of Health, Preventive Medicine Directorate, P.O. Box 54146, Riyadh 11514, Saudi Arabia. zmemish@yahoo.com

Travel Medicine and Infectious Disease
|February 25, 2011
PubMed

Insights

Meningococcal disease, especially serogroup W-135, is a concern in Gulf Cooperation Council (GCC) States, particularly during Hajj and Umrah pilgrimages. Experts discussed epidemiology and new conjugate vaccines for better prevention.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • Meningococcal disease poses a significant risk in Gulf Cooperation Council (GCC) States, exacerbated by Hajj and Umrah pilgrimages.
  • Serogroup W-135 is currently the most prevalent cause of meningococcal disease in the GCC region.
  • Previous outbreaks have been linked to pilgrimages and spread among travelers and their contacts.

Purpose of the Study:

  • To update the understanding of meningococcal disease epidemiology in GCC States.
  • To review current vaccination practices for meningococcal disease prevention in the region.
  • To explore the potential of novel conjugate vaccines for enhanced disease control.

Main Methods:

  • Convened a meeting of the GCC States Meningitis Study Group, including experts from Saudi Arabia, Bahrain, Kuwait, Qatar, Oman, and UAE.
  • Experts provided updated epidemiological data and information on current vaccination strategies.
  • Discussion focused on emerging trends and future prevention approaches.

Main Results:

  • The most prevalent meningococcal serogroup in GCC States is W-135.
  • Polysaccharide vaccines have offered protection, but novel conjugate vaccines are under consideration.
  • Recent epidemiological data for some countries were not readily available prior to this meeting.

Conclusions:

  • Continued surveillance and updated epidemiological data are crucial for effective meningococcal disease control in GCC States.
  • Novel conjugate vaccines represent a promising avenue for improving prevention strategies.
  • Collaborative efforts among GCC nations are essential for addressing the burden of meningococcal disease.

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...